SINOVAC BIOTECH LTD Share-based Payment Arrangement, Expense
SINOVAC BIOTECH LTD (SVA) reported Share-based Payment Arrangement, Expense of $0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-06-05
| Period end | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-06-05 | |
| 2024-12-31 | $0.00 20-F · filed 2026-06-05 | |
| 2023-12-31 | $0.00 20-F · filed 2026-06-05 | |
| 2022-12-31 | $0.00 20-F · filed 2026-04-30 | |
| 2021-12-31 | $7.74M 20-F · filed 2026-04-30 | |
| 2020-12-31 | $10.20M 20-F · filed 2023-05-01 | |
| 2019-12-31 | $3.00M 20-F · filed 2022-04-29 | |
| 2018-12-31 | $4.30M 20-F · filed 2021-04-22 | |
| 2017-12-31 | $979.00K 20-F · filed 2020-04-30 | |
| 2016-12-31 | $2.41M 20-F · filed 2019-04-29 | |
| 2015-12-31 | $952.00K 20-F · filed 2018-05-11 | |
| 2014-12-31 | $287.00K 20-F · filed 2017-11-22 | |
| 2013-12-31 | $281.00K 20-F · filed 2016-04-25 | |
| 2012-12-31 | $347.00K 20-F · filed 2015-04-29 | $347.23K 20-F/A · filed 2013-05-23 |
| 2011-12-31 | $206.00K 20-F · filed 2014-04-16 | $206.30K 20-F/A · filed 2013-05-23 |
| 2010-12-31 | $459.90K 20-F/A · filed 2013-05-23 |